UK Medical Oxygen Concentrators Market Overview
As per MRFR analysis, the UK Medical Oxygen Concentrators Market Size was estimated at 126.75 (USD Million) in 2023. The UK Medical Oxygen Concentrators Market Industry is expected to grow from 134.62(USD Million) in 2024 to 507.18 (USD Million) by 2035. The UK Medical Oxygen Concentrators Market CAGR (growth rate) is expected to be around 12.815% during the forecast period (2025 - 2035).
Key UK Medical Oxygen Concentrators Market Trends Highlighted
The UK Medical Oxygen Concentrators Market is currently witnessing several key market drivers that are shaping its landscape. The aging population in the UK, which is projected to grow significantly, has led to an increase in respiratory diseases such as COPD and asthma. This demographic shift is contributing to a higher demand for oxygen therapy solutions, including concentrators, as patients seek more effective management of their conditions. Additionally, the trend towards home healthcare is gaining momentum, driven by the desire for user-friendly devices that allow patients to receive care in the comfort of their homes while also reducing the burden on healthcare facilities.
Opportunities abound in the UK market, particularly as technological advancements continue to enhance the functionality and portability of medical oxygen concentrators. The introduction of lightweight, compact, and battery-operated models is opening doors for market players to cater to a broader segment of patients, including those who are more mobile. The UK government’s focus on improving air quality and public health further strengthens the prospects for enhanced oxygen therapy solutions as initiatives aimed at combating pollution and respiratory illnesses gain traction.
Trends in recent times indicate a growing acceptance of telemedicine and remote monitoring in conjunction with oxygen therapy.Patients are increasingly being monitored remotely, enhancing compliance and providing healthcare professionals with vital data for better treatment decisions. Moreover, the emergence of new distribution channels, such as online sales platforms, is making oxygen concentrators more accessible to end-users across the UK. As this market continues to evolve, it aligns with the broader goals of the National Health Service in promoting patient-centric care and ensuring that all individuals have access to necessary medical resources.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
UK Medical Oxygen Concentrators Market Drivers
Increasing Prevalence of Respiratory Diseases
The growing incidence of chronic respiratory conditions, including asthma and Chronic Obstructive Pulmonary Disease (COPD), is a major factor propelling the UK medical oxygen concentrators market. Over 1.2 million individuals in the UK already have COPD, according to current figures. As the population ages and smoking-related illnesses rise, this number is predicted to rise. The National Health Service (NHS) reports that respiratory conditions make up a significant percentage of hospital admissions; COPD alone causes over 115,000 admissions each year.
Because patients need home oxygen therapy to manage their conditions, this increase raises the demand for medical oxygen concentrators. This creates numerous opportunities for suppliers and manufacturers in the UK Medical Oxygen Concentrators Market Industry to broaden their product offerings and meet the demands of healthcare providers. Additionally, groups like the British Lung Foundation and Asthma UK are aggressively raising patient awareness and management techniques, which is driving market expansion by raising demand for oxygen therapy products.
the Technological Advancements in Medical Devices
The advancement of technology in medical devices is a significant driver for the UK Medical Oxygen Concentrators Market Industry. Recent developments have led to the emergence of portable and more efficient oxygen concentrators that provide enhanced user-friendly features. For instance, innovations such as continuous flow technology and advanced filtration systems are not only improving the efficacy of oxygen delivery but are also making these devices more accessible to patients and healthcare providers.
The NHS has endorsed such technological strides by highlighting the importance of efficient oxygen therapy in improving patient outcomes. In the past decade, the introduction of lightweight and battery-operated oxygen concentrators has allowed greater mobility for users, significantly enhancing their quality of life. This shift toward modernized equipment is fueling market growth and positioning established manufacturers such as Philips and Invacare to capture a larger share of the UK Medical Oxygen Concentrators Market.
Rising Elderly Population and Associated Health Needs
The UK's elderly population is rapidly growing, which is expected to boost the UK Medical Oxygen Concentrators Market Industry significantly. Data from the Office for National Statistics (ONS) reveals that by 2030, individuals aged 65 and over are predicted to account for over 23% of the UK population. This demographic shift correlates strongly with the increased prevalence of age-related respiratory diseases, creating an urgent requirement for home healthcare solutions, including medical oxygen concentrators.
As the elderly population increases, the demand for medical oxygen solutions, especially for those with chronic respiratory issues, is projected to rise. The rising trend towards aging in place, reinforced by government initiatives, is further encouraging patients to pursue at-home therapeutic options, thereby creating a supportive environment for market growth within the UK Medical Oxygen Concentrators Market Industry. Organizations such as Age UK emphasize the importance of supporting the elderly, which in turn fuels demand for oxygen therapy devices.
UK Medical Oxygen Concentrators Market Segment Insights
Medical Oxygen Concentrators Market Product Type Insights
The UK Medical Oxygen Concentrators Market exhibits a diverse range of product types, primarily classified into Portable Oxygen Concentrators and Stationary Oxygen Concentrators. Portable Oxygen Concentrators are increasingly popular among patients requiring mobility without sacrificing oxygen supply, representing a major demand driven by lifestyle preferences and the increasing need for home healthcare solutions.
These concentrators facilitate active patient lifestyles, making them crucial for individuals with chronic respiratory conditions who need regular oxygen therapy.Conversely, Stationary Oxygen Concentrators typically cater to patients who spend much of their time at home, offering a continuous supply of oxygen for more comprehensive care. This type is preferred for its higher output capabilities and often longer lifespan, addressing the needs of individuals with more severe health conditions. In the growing landscape of the UK Medical Oxygen Concentrators Market, both product types play a significant role in meeting patient needs, influencing market growth by providing essential support for varying levels of oxygen therapy requirements.
While Portable Oxygen Concentrators dominate in terms of flexibility and convenience, Stationary Oxygen Concentrators hold substantial value in providing robust oxygen therapy for patients with chronic illnesses. The segmentation of the market highlights how manufacturers are innovating to enhance product features, driven by consumer trends towards portability and convenience, as well as the rise in chronic respiratory diseases. The rising aging population in the UK, coupled with increasing awareness and advancements in healthcare technology, further propels the demand for innovative solutions in both categories, ensuring continued market growth.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Medical Oxygen Concentrators Market Technology Insights
The Technology segment of the UK Medical Oxygen Concentrators Market comprises various innovative solutions that cater to the growing demand for portable and efficient oxygen delivery systems. Continuous Flow and Pulse Dose are two prominent types within this segment. Continuous Flow technology provides a steady stream of oxygen, making it ideal for patients who require a constant supply, such as those with chronic respiratory conditions.
This method is widely adopted due to its reliability and ease of use. On the other hand, Pulse Dose technology is gaining traction as it offers a more efficient oxygen delivery option, activating only during inhalation, thereby optimizing oxygen usage and enhancing patient comfort.The rising prevalence of respiratory ailments and an increasing elderly population in the UK are key factors driving the demand for these technologies.
Additionally, advancements in technology are fostering the development of lighter, more compact devices that are easier for patients to manage. These factors contribute significantly to the overall growth of the UK Medical Oxygen Concentrators Market and underscore the importance of each technology in improving patient care and outcomes.
Medical Oxygen Concentrators Market Indication Insights
The UK Medical Oxygen Concentrators Market, categorized under the Indication segment, displays a significant presence driven largely by the increasing prevalence of Chronic Obstructive Pulmonary Disease (COPD), asthma, and sleep apnea among the aging population. COPD represents a major health concern in the UK, accounting for a substantial portion of respiratory diseases, leading to a growing demand for home healthcare solutions, including oxygen concentrators.
The rising diagnosis of asthma, influenced by environmental factors and allergies, further propels the requirement for supplemental oxygen interventions.Additionally, sleep apnea's rising awareness and diagnosis contribute to the market's expansion, as effective management of this condition often necessitates oxygen therapy. Other factors, such as increased hospital admissions due to respiratory distress and innovations in oxygen delivery technologies, are also enhancing the market dynamics.
These indications collectively underscore the critical role that oxygen concentrators play in patient management while also presenting opportunities for market growth within the UK medical industry. As healthcare providers focus on offering patient-centered care, the demand for reliable, efficient, and portable medical oxygen solutions continues to climb, illustrating robust forecasting of the UK Medical Oxygen Concentrators Market data in the coming years.
Medical Oxygen Concentrators Market End User Insights
The End User segment of the UK Medical Oxygen Concentrators Market plays a crucial role in the market's landscape. It can be categorized into three main areas: Hospitals and Clinics, Homecare Settings, and Others. Hospitals and Clinics remain a dominant segment due to the high demand for medical oxygen in emergency care and respiratory treatments, with healthcare facilities increasingly investing in advanced technologies to enhance patient care. Homecare Settings are also gaining traction, propelled by the rise in chronic respiratory diseases and an aging population that favors at-home treatment options, offering convenience and flexibility for patients and caregivers alike.
The 'Others' category encompasses various niche markets, such as rehabilitation centers and long-term care facilities, which are becoming significant as they adopt medical oxygen solutions to cater to specialized patient needs. With the increasing focus on improving healthcare outcomes and the push towards patient-centered care in the UK, this segmentation is expected to evolve and expand, highlighting the importance of access to oxygen therapy across different healthcare environments. Overall, the End User segment reflects critical trends and growth opportunities within the UK Medical Oxygen Concentrators Market as it adapts to the changing dynamics in healthcare provision.
UK Medical Oxygen Concentrators Market Key Players and Competitive Insights
The UK Medical Oxygen Concentrators Market is characterized by a dynamic competitive landscape shaped by technological advancements, a growing patient population with respiratory conditions, and increasing awareness about home healthcare solutions. The market comprises a mix of established players and emerging companies, each striving to capture market share through innovative products and enhanced service offerings.
Several factors influence competition, including product quality, pricing strategies, distribution channels, and the ability to forge partnerships with healthcare providers. The ongoing demand for oxygen therapy devices, driven by the rising prevalence of chronic obstructive pulmonary disease and other respiratory illnesses, presents a lucrative opportunity for businesses in this field. Companies in the market are focusing on research and development to launch advanced and more efficient oxygen concentrators while also navigating regulatory requirements to ensure product compliance and safety.Chart Industries has established a strong presence in the UK Medical Oxygen Concentrators Market with its high-quality product offerings and innovative technologies.
The company benefits from its extensive experience in the field of gas separation and liquefaction. Chart Industries is known for its state-of-the-art oxygen concentrators that combine reliability with user-friendly features, catering to both healthcare facilities and home users. The company's commitment to sustainability and efficient energy consumption aligns well with increasing environmental concerns in the UK, enhancing its appeal among eco-conscious consumers.
Furthermore, Chart Industries has developed strategic partnerships within the healthcare ecosystem, allowing the company to leverage synergies and expand its market reach effectively. The firm’s robust distribution network and customer support services further strengthen its competitive position in the marketplace.Mediwatch also plays a significant role in the UK Medical Oxygen Concentrators Market with its wide range of products designed for respiratory care. The company is well-regarded for its focus on product innovation, having developed several technologically advanced oxygen concentrators tailored to meet the needs of patients in diverse environments.
Mediwatch emphasizes quality and reliability, positioning itself as a trusted brand among healthcare providers and patients alike. Additionally, the company has engaged in strategic mergers and acquisitions to enhance its product portfolio and distribution capabilities, thereby increasing its market presence in the UK. Mediwatch’s offerings include portable and stationary oxygen concentrators, which cater to the growing demand for flexible oxygen therapy solutions. The company's strengths lie in its strong focus on customer service, product training, and after-sales support, which help in building long-term relationships with customers and improving patient outcomes.
Key Companies in the UK Medical Oxygen Concentrators Market Include
- Chart Industries
- Mediwatch
- Zechin Medical
- OxyGo
- Nidek Medical Products
- Caire Inc
- Tillomed Laboratories
- Philips
- Ozark Medical
- Linde Healthcare
- Invacare
- Drive DeVilbiss Healthcare
- GCE Healthcare
- Inogen
- AirSep
UK Medical Oxygen Concentrators Market Industry Developments
The UK Medical Oxygen Concentrators Market has experienced significant developments recently, particularly in response to the ongoing health challenges faced by the population. Key players such as Chart Industries, Mediwatch, and Philips have reported a noticeable increase in demand for oxygen concentrators due to respiratory conditions exacerbated by the COVID-19 pandemic. In September 2023, Invacare and Drive DeVilbiss Healthcare announced enhancements in their product offerings, focusing on more efficient and portable oxygen concentrators. The market valuation for oxygen concentrators has been boosted by increased healthcare spending and growing awareness of home healthcare solutions.
In June 2023, Linde Healthcare completed the acquisition of OxyGo, integrating its advanced technology to improve oxygen delivery systems. Other notable happenings include ongoing collaborations among GCE Healthcare and Caire Inc. to develop innovative solutions for homecare settings. The focus on patient-centered care has driven investments in Research and Development among these companies. Furthermore, the restrictive regulatory environment continues to be a critical factor, influencing the lifecycle and launch of new oxygen concentrator models across the UK, catering to the rising demand for reliable and efficient respiratory aids.
UK Medical Oxygen Concentrators Market Segmentation Insights
Medical Oxygen Concentrators Market Product Type Outlook
- Portable Oxygen Concentrators
- Stationary Oxygen Concentrators
Medical Oxygen Concentrators Market Technology Outlook
- Continuous Flow
- Pulse Dose
Medical Oxygen Concentrators Market Indication Outlook
- Chronic Obstructive Pulmonary Disease
- Asthma
- Sleep Apnea
- Others
Medical Oxygen Concentrators Market End User Outlook
- Hospitals and Clinics
- Homecare Settings
- Others
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2023 |
126.75(USD Million) |
MARKET SIZE 2024 |
134.62(USD Million) |
MARKET SIZE 2035 |
507.18(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
12.815% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Million |
KEY COMPANIES PROFILED |
Chart Industries, Mediwatch, Zechin Medical, OxyGo, Nidek Medical Products, Caire Inc, Tillomed Laboratories, Philips, Ozark Medical, Linde Healthcare, Invacare, Drive DeVilbiss Healthcare, GCE Healthcare, Inogen, AirSep |
SEGMENTS COVERED |
Product Type, Technology, Indication, End User |
KEY MARKET OPPORTUNITIES |
Aging population demand rise, Chronic respiratory disease prevalence increase, Homecare market growth acceleration, Innovations in portable devices, Government health initiatives expansion |
KEY MARKET DYNAMICS |
Growing geriatric population, Increasing respiratory diseases, Technological advancements, Rising healthcare expenditure, Homecare trend expansion |
COUNTRIES COVERED |
UK |
Frequently Asked Questions (FAQ) :
The market is expected to be valued at 134.62 million USD in 2024.
By 2035, the market is anticipated to reach a value of 507.18 million USD.
The expected CAGR for the market is 12.815% during the forecast period from 2025 to 2035.
Stationary Oxygen Concentrators hold the largest market share with an expected value of 80.62 million USD in 2024.
The market size for Portable Oxygen Concentrators is projected to reach 204.5 million USD by 2035.
Major players include Chart Industries, Philips, Invacare, and OxyGo among others.
Key trends include the rising demand for home healthcare and advancements in oxygen concentrator technology.
Opportunities exist in the expansion of portable oxygen concentrators and increasing utilization in elderly care.
The UK market is characterized by specific regulatory standards and a diverse range of medical applications.
Challenges include regulatory hurdles and competition from alternative respiratory therapies.